LGI1 and Cognitive impairment: Patients with anti-LGI1 encephalitis who presented with cognitive impairments had significantly higher mRS scores on admission (p < 0.001, Figure 2C) and at the 6-month follow-up examination (p = 0.018, Figure 2D) than those without cognitive impairment symptoms.